Short Wave Folgen

Scientists have been trying to figure out how to eradicate malaria for decades. Globally, a child under the age of five dies from the disease every two minutes, and even for kids who do survive there can be long term complications. A big breakthrough finally came in October when the World Health Organization endorsed MoSQUIRIX, the first malaria vaccine. It has relatively low efficacy, just about 30%, but malaria researcher Winter Okoth explains how the new vaccine could still make a big difference.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

(Encore) The Pfizer-BioNTech and Moderna COVID-19 vaccines are the first authorized vaccines in history to use mRNA technology. In light of the authorization for some children and teens now, we are encoring the episode in which Maddie Sofia chats with Dr. Margaret Liu, a physician and board chair of the International Society for Vaccines, about the history and science behind these groundbreaking vaccines. We'll also ask what we can expect from mRNA vaccines in the future. Have a question for us? Send a note to shortwave@npr.org — we'd love to hear it.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

NPR climate correspondents Lauren Sommer and Dan Charles join the show before the UN Climate Change Conference in Glasgow, Scotland (COP26) starts on Sunday. Diplomats, business executives, climate experts, and activists from all around the world will gather to discuss the question: Is the world on track to avoid the worst effects of climate change?Lauren and Dan introduce us to two climate activists from countries that will be heavily impacted by climate change. Hilda Flavia Nakabuye from Uganda and María Laura Rojas from Colombia. We learn what's at stake for them if powerful countries don't move faster to halt climate change.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy